Recursion Pharmaceuticals

RXRX

NASDAQHealth Care

Income Statement

Total Revenue$58.84M

Gross Profit$13.6M

Operating Income$-479.01M

EBITDA$-411.68M

EBIT$-464.79M

Pre-tax Income$-715.69M

Net Income$-463.66M

Cash Equivalent$450.56M

Total Debt$84.99M

Book Value$636.24M

Book Value Per Share2.45

Return on Equity (ROE)-44.81%

Return on Assets (ROA)-32.01%

Return on Invested Capital (ROI)-43.65%

Net Profit Margin-788.02%

Current Ratio3.81

Quick Ratio3.81

Long-Term Debt / Equity0.00